Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
ID: 353310Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 1, 2024 12:00 AM
  4. 4
    Due Aug 9, 2024 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)". This opportunity falls under the category of Health and is a Cooperative Agreement. The purpose of this funding opportunity is to solicit applications for the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP). The program aims to address the immunologic and physiologic barriers to safe and efficacious xenotransplantation using preclinical pig to nonhuman primate (NHP) or human decedent models of pancreatic islet, kidney, heart, lung, or liver xenotransplantation. The grant does not require cost sharing or matching. The deadline for applications is August 9, 2024. For more information and to apply, please visit the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-020.html. For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
Files
Title
Posted
Similar Opportunities
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)". This opportunity falls under the category of Health and is a Cooperative Agreement. The purpose of this notice is to solicit applications for the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP). The program aims to address immunologic and physiologic barriers to safe and efficacious xenotransplantation using preclinical pig to nonhuman primate (NHP) or human decedent models of pancreatic islet, kidney, heart, lung, or liver xenotransplantation. The grant does not require cost sharing or matching. The deadline for applications is August 9, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-019.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-019.html). If you have any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)". This opportunity falls under the category of Health and is a Discretionary grant. The funding instrument type is a Cooperative Agreement. The grant does not require cost sharing or matching. The purpose of this funding opportunity is to support the implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated with high-risk clinical trials. Mechanistic work in clinical trials is important as it promotes the understanding of human diseases and the development of future therapeutic modalities. Eligible applicants for this grant include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territories or Possessions. The close date for this grant opportunity is January 13, 2027, and the archive date is February 18, 2027. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-100.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-100.html). For any inquiries or additional information, please contact NIH Grants Information at grantsinfo@nih.gov.
Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)". This grant aims to support research in three main areas: 1) defining associations between variations in HLA and KIR genetic regions and immune-mediated diseases, 2) elucidating mechanisms underlying these associations to advance therapeutic opportunities, and 3) validating association data to improve the predictive power of clinical disease screening. The grant is a Cooperative Agreement and falls under the category of Health. The funding opportunity does not require cost sharing or matching. The maximum award ceiling is $400,000. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, non-domestic (non-U.S.) Entities (Foreign Organizations) and non-domestic components of U.S. Organizations are not eligible to apply. The grant opportunity will close on August 20, 2024, and the archive date is set for September 25, 2024. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-017.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-017.html). If there are any inquiries, they can be directed to NIH Grants Information at grantsinfo@nih.gov.